AQUILON PHARMACEUTICALS
Personnes
13
Sites
4
Publications
13
Profil de l'entreprise
Date de création
16 octobre 2013
Dernier bilan (année)
2024
Forme juridique
Naamloze vennootschap
Type d'entreprise
Rechtspersoon
Activité
72101 - Speur- en ontwikkelingswerk op biotechnologisch gebied
Âge de l'entreprise
13 ans
Coordonnées
Unlock direct contact points, registry address detail, and website links for AQUILON PHARMACEUTICALS.
Unlock Contact Details
Reveal email, phone, website, and full registry contact information.
Create Free AccountHistorique Financier
| KPI | 2024 | 2023 | 2022 |
|---|---|---|---|
| Chiffre d'affaires | - | - | - |
| Marge brute | 991 768 € (+8.1%) | 917 235 € (+103.3%) | 451 097 € (+190.4%) |
| Bénéfice | -913 660 € (+2.5%) | -936 675 € (-22.8%) | -762 477 € (-21.2%) |
| EBITDA | -470 572 € (+5.7%) | -498 758 € (-5.5%) | -472 735 € (+15.7%) |
| Capitaux propres | 1 296 242 € (-30.4%) | 1 863 008 € (+144.9%) | 760 758 € (-50.1%) |
| Dettes | 8 976 765 € (+13.6%) | 7 905 296 € (+12.1%) | 7 053 414 € (+47.7%) |
| Total des actifs | 10 306 004 € (+5.3%) | 9 784 947 € (+25.2%) | 7 815 276 € (+24.1%) |
| Trésorerie | 208 427 € (-61.1%) | 535 282 € (-11.3%) | 603 141 € (-41.2%) |
| ETP (FTE) | 9,4 (+2.2%) | 9,2 (+12.2%) | 8,2 (+17.1%) |
Unlock Full History
Create a free account to access up to 10 years of historical financial data for AQUILON PHARMACEUTICALS.
Create Free AccountSanté Financière
Ratio-level insight derived from the latest company and balance sheet data.
Current Ratio
0,1x
(-56.0%)
Quick Ratio
0,1x
(-56.0%)
Solvency
12,6%
(-33.9%)
Debt / Equity
6,9x
Unlock Advanced Metrics
Access the full ratio deck, benchmarking signals, and deeper profitability diagnostics.
Create Free AccountImplantations & Empreinte
Establishment
AdresseAucune donnée disponible
Establishment
AdresseAucune donnée disponible
Establishment
AdresseAucune donnée disponible
Unlock Full Footprint
See every known establishment, linked address, and operating footprint tied to AQUILON PHARMACEUTICALS.
Create Free AccountRéseau d'entités
First-level relations linked directly to AQUILON PHARMACEUTICALS. Unlock second-level relations for deeper graph exploration.
AQUILON PHARMACEUTICALS
Actif
- MAES PHARMCONSULT
Incoming link
Administrator Legal - SAMBRINVEST SPIN-OFF/SPIN-OUT
Incoming link
Administrator Legal - SCALE I
Incoming link
Administrator Legal -
Didier CATALDO
Incoming link
Administrator Natural -
Franck PIETERS
Incoming link
Administrator Natural -
Frank PIETERS
Incoming link
Administrator Natural -
Hassan BENAMEUR
Incoming link
Administrator Natural -
Joseph GHELDERE
Incoming link
Administrator Natural -
Michaël MELLINK
Incoming link
Administrator Natural -
Moshe MANOR
Incoming link
Administrator Natural - P&L Projects
Outgoing link
Participating Interest - SAMBRINVEST SPIN-OFF/SPIN-OUT
Outgoing link
Participating Interest - SCALE I
Outgoing link
Participating Interest -
Elisabeth DE HALLEUX
Incoming link
Administrator Legal Representative -
Gauthier VAN DER ELST
Incoming link
Administrator Legal Representative -
Gauthier VAN DER ELST Gauthier
Incoming link
Administrator Legal Representative -
Micheline Streel
Incoming link
Administrator Legal Representative -
Paul MAES
Incoming link
Administrator Legal Representative -
Thomas Donck
Incoming link
Administrator Legal Representative
Unlock Second-Level Relations
Expand beyond direct links to see second-level entities, people, and cross-company paths.
Free Sign UpDirection & Personnes Clés
Unlock linked people, governance roles, and enriched demographic signals associated with AQUILON PHARMACEUTICALS.
Management Profiles
Unlock directors, managers, role history, plus inferred gender and age where available.
Create Free Account